{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:50:42Z","timestamp":1767383442217,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":1680,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.4103\/0255-0857.188329","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T23:53:17Z","timestamp":1471305197000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent"],"prefix":"10.1016","volume":"34","author":[{"given":"P","family":"Ranjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GJ","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PS","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"UG","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/0255-0857.188329_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.4103\/0255-0857.188329_bib2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.188329_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cll.2012.03.003","article-title":"Viral hepatitis in India","volume":"32","author":"Abraham","year":"2012","journal-title":"Clin Lab Med"},{"key":"10.4103\/0255-0857.188329_bib4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.188329_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0255-0857.118875","article-title":"Genotypes of hepatitis C virus in the Indian sub-continent: A decade-long experience from a tertiary care hospital in South India","volume":"31","author":"Christdas","year":"2013","journal-title":"Indian J Med Microbiol"},{"key":"10.4103\/0255-0857.188329_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"key":"10.4103\/0255-0857.188329_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.4103\/0255-0857.188329_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.4103\/0255-0857.188329_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.4103\/0255-0857.188329_bib10","doi-asserted-by":"crossref","first-page":"849373","DOI":"10.1155\/2012\/849373","article-title":"The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C","volume":"2012","author":"Bellanti","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.4103\/0255-0857.188329_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000369902","article-title":"The role of interferon-\u03bb locus polymorphisms in hepatitis C and other infectious diseases","volume":"7","author":"Griffiths","year":"2015","journal-title":"J Innate Immun"},{"key":"10.4103\/0255-0857.188329_bib12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.4103\/0255-0857.188329_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2011.09.008","article-title":"IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C","volume":"56","author":"Asselah","year":"2012","journal-title":"J Hepatol"},{"key":"10.4103\/0255-0857.188329_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1741-7015-11-6","article-title":"Meta-analysis: Implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C","volume":"11","author":"Jim\u00e9nez-Sousa","year":"2013","journal-title":"BMC Med"},{"key":"10.4103\/0255-0857.188329_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/jmv.23876","article-title":"Interleukin-28b CC genotype predicts early treatment response and CT\/TT genotypes predicts non-response in patients infected with HCV genotype 3","volume":"86","author":"Gupta","year":"2014","journal-title":"J Med Virol"},{"key":"10.4103\/0255-0857.188329_bib16","doi-asserted-by":"crossref","first-page":"e99126","DOI":"10.1371\/journal.pone.0099126","article-title":"Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients","volume":"9","author":"Firdaus","year":"2014","journal-title":"PLoS One"},{"key":"10.4103\/0255-0857.188329_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7869\/tg.187","article-title":"Association of IL28B single nucleotide polymorphism rs8099917 with response to treatment in genotype 3 HCV-infected patients from India","volume":"35","author":"Chinnaswamy","year":"2014","journal-title":"Trop Gastroenterol"},{"key":"10.4103\/0255-0857.188329_bib18","first-page":"190","article-title":"Development and validation of a simple, rapid and inexpensive PCR-RFLP method for genotyping of common IL28B polymorphisms: A useful pharmacogenetic tool for prediction of hepatitis C treatment response","volume":"12","author":"Sharafi","year":"2012","journal-title":"Hepat Mon"},{"key":"10.4103\/0255-0857.188329_bib19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.gastro.2010.05.079","article-title":"An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response","volume":"139","author":"Mangia","year":"2010","journal-title":"Gastroenterology"},{"key":"10.4103\/0255-0857.188329_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2010.07.041","article-title":"Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients","volume":"54","author":"Sarrazin","year":"2011","journal-title":"J Hepatol"},{"key":"10.4103\/0255-0857.188329_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.24154","article-title":"IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection","volume":"53","author":"Moghaddam","year":"2011","journal-title":"Hepatology"},{"key":"10.4103\/0255-0857.188329_bib22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jhep.2010.08.024","article-title":"Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin","volume":"54","author":"Scherzer","year":"2011","journal-title":"J Hepatol"},{"key":"10.4103\/0255-0857.188329_bib23","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.3748\/wjg.v19.i47.8924","article-title":"Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients","volume":"19","author":"Mangia","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.4103\/0255-0857.188329_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0973-6883(12)60098-X","article-title":"The distribution of genotype and allelic frequency of IL28B gene polymorphism in Andhra Pradesh, India","volume":"2","author":"Sivaprasad","year":"2012","journal-title":"J Clin Exp Hepatol"},{"issue":"Pt 3","key":"10.4103\/0255-0857.188329_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1099\/0022-1317-76-3-711","article-title":"Diversity of genotypes of hepatitis C virus in southern India","volume":"76","author":"Valliammai","year":"1995","journal-title":"J Gen Virol"},{"key":"10.4103\/0255-0857.188329_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1386-6532(02)00025-2","article-title":"Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in South India","volume":"26","author":"Raghuraman","year":"2003","journal-title":"J Clin Virol"},{"key":"10.4103\/0255-0857.188329_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0014-5793(02)03851-6","article-title":"The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine","volume":"535","author":"Griffin","year":"2003","journal-title":"FEBS Lett"},{"key":"10.4103\/0255-0857.188329_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.molmed.2014.02.002","article-title":"Hepatitis C treatment: An incipient therapeutic revolution","volume":"20","author":"deLemos","year":"2014","journal-title":"Trends Mol Med"},{"issue":"Suppl 1","key":"10.4103\/0255-0857.188329_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2011.02712.x","article-title":"IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: Ten years too late?","volume":"32","author":"Jensen","year":"2012","journal-title":"Liver Int"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720301389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720301389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:15:06Z","timestamp":1759346106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085720301389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0255085720301389"],"URL":"https:\/\/doi.org\/10.4103\/0255-0857.188329","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/0255-0857.188329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Indian Journal of Medical Microbiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}